Navigation Links
Surprise discovery made in cancer research
Date:12/1/2008

This release is available in German.

One of the defining characteristics of cancer cells is that they systematically prevent programmed cell death (apoptosis), with which the body guards itself against the proliferation of defective cells. In order to do this, they express so-called apoptosis inhibitors (IAPs) among other proteins.

Many of the cancer drugs currently undergoing clinical trials target IAPs, since if the levels of IAPs are reduced, tumour cells will be destroyed by the body's own self-protecting mechanism or by the chemotherapeutic drugs. However, as a research group from the Goethe University in Frankfurt, working with scientists at the Universities of Wrzburg and Philadelphia have recently discovered, IAPs also have another life: they control cell migration. Where IAP production is suppressed, there is a significant increase in C-RAF kinase, a crucial member of a signal cascade, which, among other functions, controls cell migration. This also means that when IAP levels are reduced, metastasis may be promoted unexpectedly in the absence of cell death. According to the researchers, drugs to target IAPs should therefore only be used with caution in future.

Dr. Krishnaraj Rajalingam, leader of the Emmy-Noether Group at the Institute for Biochemistry at Frankfurt's Goethe University, claims that these findings have been a great surprise. As he puts it: "Up until now, IAPs were well known for their role in apoptosis suppression, but we now realise that they can also influence other processes like cell migration". The classical mitogenic cascade (MAPK) is triggered by RAS proteins, which are activated by mutations in nearly 20 % of all human tumours. In this signalling cascade, the RAS-protein is immediately followed by the C-RAF kinase, which as the researchers report in the current issue of 'Nature Cell Biology' binds strongly to an apoptosis inhibitor (XIAP). "If we reduce the expression of some IAPs by RNA interference technique, C-RAF kinase increases in both the healthy and the cancerous human cells. As a consequence, the cells alter their form and start to move faster." Co-author Prof. Ulf R. Rapp from the University of Wrzburg, who discovered C-RAF kinase 25 years ago, claims that these findings will have a significant influence on cancer therapy.

Prof. Werner-Mller Esterl, Director of Frankfurt's Institute for Biochemistry II and the President-elect of the Goethe University, is delighted by the success of his young colleague, who took up his post at the university only a few months ago. "These are very exciting results and with such an early success, our new Emmy Noether Group has proved that the University's programme of supporting young independent scientific investigators has once again paid off."


'/>"/>

Contact: Krishnaraj Rajalingam
krishna@biochem2.de
49-069-630-15569
Goethe University Frankfurt
Source:Eurekalert  

Related medicine news :

1. Blue Cross/Blue Shield Christmas Gift to Federal Employees: Surprise, Were Cutting Your Benefits!; Patients, Doctors and Health Care Providers Outraged
2. Hey fever! The surprise benefit of allergies
3. NARALS CHOICE: Is Anyone Surprised About Out-of-the-Mainstream NARALs Choice of Barack Obama for President?
4. This Mothers Day, Surprise Mom With a New Way to Give
5. Easter Eggs May Hold Some Unwanted Surprises
6. Surprise Orgasms Baffle Women Undergoing New Infertility Treatment
7. Surprise U.S. Supreme Court Decision Helps Michigan Citizens
8. Surprise in Lab Helps ID Drug to Fight ALS
9. Med school discovery could lead to better cancer diagnosis, drugs
10. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
11. Leeds researchers reshape the future of drug discovery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Surprise discovery made in cancer research
(Date:5/2/2016)... ... 2016 , ... Dr. Philip Shindler, dentist in Agoura Hills , now ... past, many necessary dental treatments could require multiple appointments to complete. This could mean ... chair time. Not only could this be inconvenient, but it could also be overwhelmingly ...
(Date:5/2/2016)... Rhinebeck, NY (PRWEB) , ... May 02, 2016 , ... ... Valley, reopened for its 2016 guest season which runs through October. Omega is offering ... talks . , “There has never been such widespread interest in or ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... itself around major organs, such as the kidneys, liver and pancreas. If not ... M.D ., a board-certified physician in Internal Medicine, Medical Oncology and Palliative Care, ...
(Date:5/2/2016)... ... May 02, 2016 , ... Pregnancy Awareness Month offers a great time ... , “If you are ready to have a baby, it’s best to get ... Journal Babies is your Personal Conception & Pregnancy Organizer, written for women who plan ...
(Date:5/2/2016)... PARSIPPANY, N.J. (PRWEB) , ... May 02, 2016 ... ... - Healthcare Research & Analytics EVP and GM Jim Callandrillo and Duane ... during the 55th Annual Pharmaceutical Business Intelligence and Research Group (PBIRG) General ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... FREMONT, Calif. , April 28, 2016 ... Enterprise Validation Lifecycle Management Solutions (VLMS) today ... products and services for sufferers of chronic ... management System to manage their corporate validation ... been seeking a software solution to manage ...
(Date:4/27/2016)... PARIS , le 27 Avril 2016 /PRNewswire/ ... chiffre d,affaires a progressé de +5% sur le ... ventes récurrentes de consommables  Croissance de ... Mauna Kea Technologies (Euronext : ... multidisciplinaire d,endomicroscopie confocale laser, annonce aujourd,hui son chiffre ...
Breaking Medicine Technology: